ENA screen chemiluminescence immunoassay: a random access method in autoimmunology.
Recently, autoimmunity, due to an increase in examination requests, has become an independent area of laboratory research, which needs management optimization in terms of quality, time, and flexibility. Therefore, we have evaluated the screening of extractable nuclear antigens (ENA) antibodies both with a chemiluminescence immunoassay and the enzyme-linked immunosorbent assay (ELISA) method, which was used in our laboratory, as a reference kit. The most important difference between these two methods is the possibility of processing serum samples with a random access system, which is different from batch methods.
Signorini
S
S
Centro Analisi FlemingLabs, Brescia, Italy. simona.signorini@fleming.it
Kutschera
I
I
Capuano
F
F
Lattuada
L
L
D034961:Antigens, Nuclear / Q000097:blood* / Q000276:immunology*; D015551:Autoimmunity / Q000276:immunology*; D003625:Data Collection / Q000379:methods*; D006801:Humans; D007118:Immunoassay / Q000379:methods*; D008163:Luminescent Measurements / Q000379:methods*; D008403:Mass Screening / Q000379:methods*